Eugenics and the outer limits of good breeding
By Juliana Edelman,
The Irish Times
| 02. 09. 2017
It hasn’t gone away, you know: Victorian junk science has its race-baiting adherents
When I teach Irish university students about eugenics as part of the history of science and medicine, I observe gratifying looks of incredulity – often followed by outbursts of horror and disgust.
Eugenics, a science popular in the late 19th and early 20th centuries, aimed to encourage governments to favour the reproduction of the most “fit” members of society and to reduce or even prevent the reproduction of those considered less fit. My students immediately hone in on the injustice of self-selected individuals deciding what constitutes fitness to reproduce. I use the example of eugenics because it shocks them into understanding that science and medicine are not neutral and can be used to forward social agendas.
Eugenics was a specific extension of evolutionary ideas often termed social Darwinism. Eugenics societies flourished around Europe and the US in the early 1900s, but were particularly prominent in Britain, where its promoters included a number of leading evolutionary scientists.
Drawing on both evolutionary science and an understanding of livestock...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Antonio Regalado, MIT Technology Review | 06.05.2025
Brian Armstrong, the billionaire CEO of the cryptocurrency exchange Coinbase, says he’s ready to fund a US startup focused on gene-editing human embryos. If he goes forward, it would be the first major commercial investment in one of medicine’s most...